Infectious Dis. Medical News

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Use of Tumor Necrosis Factor-alpha-blocking Agents in Hepatitis B Virus-positive Patients: Reports of 3 Cases and Review of the Literature
Journal of Rheumatology, 06/18/09

Zingarelli S et al. - TNFBA should be avoided in patients with active HBV replication and should be used with caution in inactive HBsAg carriers. In these patients, the risk of viral reactivation seems to be high, but it might be reduced by prophylactic LAM, which should probably be given for a long time when TNFBA are discontinued (e.g., 12 mo). Potential occult carriers might carry a low, but not negligible, risk of viral reactivation. They should therefore be monitored with particular care.

<< Previous
Pulmonary nocardiosis from a tertiary care hospital in Southern...

Next >>
Initial Results of Managing Severe Bone Loss in Infected Total...